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ABSTRACT 
 
Skin Cancer Detection by Oblique-Incidence Diffuse Reflectance Spectroscopy. 
(December 2006) 
Elizabeth Brooks Smith, B.E., Vanderbilt University 
Chair of Advisory Committee: Dr. Lihong Wang 
 
 
Skin cancer is the most common form of cancer and it is on the rise.  If skin cancer is 
diagnosed early enough, the survival rate is close to 90%.  Oblique-incidence diffuse 
reflectance (OIR) spectroscopy offers a technology that may be used in the clinic to aid 
physicians in diagnosing both melanoma and non-melanoma skin cancers.  The system 
includes a halogen light source, a fiber optic probe, an imaging spectrograph, a charge 
coupled device (CCD) camera, and a computer.  Light is delivered to the skin surface via 
optical fibers in the probe.  After interacting with the skin, the light is collected and sent 
to the spectrograph that generates optical spectra.  Images and histopathological 
diagnoses were obtained from 250 lesions at the University of Texas M.D. Anderson 
Cancer Center (Melanoma and Skin Center).  To classify OIR data, an image processing 
algorithm was developed and evaluated for both pigmented and non-pigmented lesions.  
The continuous wavelet transform and the genetic algorithm were employed to extract 
optimal classification features.  Bayes decision rule was used to categorize spatio-
spectral images based on the selected classification features.  The overall classification 
accuracy for pigmented melanomas and severely dysplastic nevi is 100%.  The overall 
  
iv
classification accuracy for non-pigmented skin cancers and severely dysplastic nevi is 
93.33%.  Oblique-incidence diffuse reflectance spectroscopy and the developed 
algorithms have high classification rates and may prove useful in the clinic as the 
process is fast, noninvasive and accurate.    
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CHAPTER I 
INTRODUCTION 
 
1.1 Overview of Skin Cancer 
Skin cancer is the most common form of cancer and it is on the rise.  Non-melanoma 
skin cancers account for half of all cancers and include basal cell carcinomas and 
squamous cell carcinomas.  Basal cell carcinomas begin in the basal cell layer of the 
epidermis.  The tumor cells continue dividing but do not differentiate any further.  
Squamous cell carcinomas develop from dividing keratinocytes in a higher level of the 
epidermis.  The American Cancer Society estimates that there will be 1 million new 
cases of non-melanoma skin cancers in the U.S. this year1.  Melanoma is the most 
serious and fatal type of skin cancer.  Melanoma skin cancers arise from melanocytes in 
the nueral crest.  The American Cancer Society estimates that there will be 62,000 new 
cases of melanoma in the U.S. this year with 8,000 people dying of the disease1.  Skin 
cancer is difficult to diagnose non-invasively as malignant skin lesions can closely 
resemble their benign counterparts. 
 
There are many kinds of lesions that can be mistaken for skin cancer or vice versa.  The 
most common types include common nevi (moles), dysplastic nevi, warts, seborrheic 
keratosis, and actinic keratosis.  Common nevi are benign growths formed by clusters of  
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melanocytes in the basal layer of the epidermis or the top layers of the dermis.  
Dysplastic nevi have atypical size, shape, and organization of cells.  They are more 
likely to turn into melanoma than common nevi and are graded mild, moderate or severe.  
Mild and moderate dysplastic nevi do not have to be removed but should be watched 
closely.  Severe dysplastic nevi are always removed completely as they have 
resemblance of melanoma.  Warts are harmless skin growths caused by a virus.  Often 
times they go away by themselves, though some may need treatment.  Seborrheic 
keratoses are benign wart-like tumors that are very common in people over 40.  Actinic 
keratosis is a precancerous skin tumor caused by sun exposure and known in some cases 
to turn into squamous cell carcinoma.  Different lesion types can have similar 
characteristics furthering the problem in discriminating between them.     
 
1.2 Current Methods of Diagnosis 
If skin cancer is diagnosed early enough, the survival rate is close to 90%.  Visual 
examination is used in the clinic to determine whether a skin lesion may be cancerous.  
ABCDE represents common guidelines that are helpful in identifying skin cancer.  
Asymmetry (A), irregular border (B), variety of colors (C), large diameter (D), and 
evolving lesions (E) are symptoms of melanoma.  Accuracy is partially determined by 
practice, but even the most experienced physician will be unable to diagnose certain 
lesions as many features are shared by benign and malignant tumors.  It remains crucial 
that non-melanoma, melanoma, and benign tumors be differentiated during early stages.  
Dermoscopy decreases skin refraction and improves resolution of epidermal structures 
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and the nevoscope uses polarized light for imaging of skin lesions.  Both of these 
methods add to the physician’s accuracy but still leave a considerable margin for error.  
Questionable lesions must be biopsied as histopathology is the gold standard for 
diagnosis.  This leads to many unnecessary biopsies that can be painful, costly, and slow 
to yield results.  A non-invasive accurate method of diagnosis is needed in the clinic.   
  
4
CHAPTER II 
BACKGROUND 
 
 
2.1 Optical Imaging Basics 
X-ray, MRI, and ultrasound are imaging modalities commonly used in medical practice.  
Optical imaging is new to the field and has many interesting advantages.  (1) Optical 
photons are non-ionizing offering a technology that is safe for patients.  (2) Optical 
spectra are related to molecular conformation of biological tissue.  (3) Optical absorption 
is related to angiogenesis, hyper-metabolism, and cell death.  (4) Optical scattering can 
be used to measure the size of scattering particles.  (5) The Doppler Effect can be used to 
image blood flow.  This research analyzes optical spectra of diffusely reflected light to 
discriminate between benign and cancerous tumors. 
 
When light interacts with biological tissue, photons can be reflected, absorbed, scattered, 
or transmitted.  Light that is immediately reflected when hitting the surface of the 
medium is termed specular reflectance.  Photons that go through a series of absorption 
and scattering events before being reemitted at the top and bottom of the medium are 
considered diffuse reflectance and transmittance, respectively.  Absorption is when 
energy is deposited into the medium as an electron is moved from the ground state of a 
molecule to the excited state.  A scattering event occurs when a photon is deflected into 
a new direction.  When photons first enter the medium, they are considered to be in the 
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ballistic regime as they are mostly forward directed.  Once they begin to scatter in 
different directions isotropically, they are in the diffusion regime.  
 
Biological tissue is considered scattering media as there is little absorption.  Biological 
scatterers are primarily cell nuclei and mitochondria, with diameters ranging from 1 μm 
to 8 μm.  The wavelengths used for this research are smaller than these scatterers, so the 
light interaction can be predicted by Mie scattering theory, which is an exact analytical 
solution of Maxwell’s electromagnetic field equations.  When the scattering particles are 
much smaller than the wavelength, the light interaction can be predicted by Raleigh 
scattering theory, which is a limiting case of Mie theory.  Scattering coefficient is 
defined as the probability of photon scattering per unit infinitesimal pathlength.   
 
In the visible range, the most significant absorbers in biological tissue include 
oxygenated hemoglobin, deoxygenated hemoglobin, and melanin.  The concentration of 
each absorber can be calculated by measuring the absorption at different wavelengths.  
Absorption coefficient is defined as the probability of photon absorption per unit 
infinitesimal pathlength.  When light propagates along x through an absorbing medium 
with absorption coefficient μa, the intensity varies according to Equation 2.1 
 ( )xII aμ−= exp0  (2.1) 
where I0 is the initial intensity.  This is commonly known as Beer’s Law.   
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The Monte Carlo technique is very useful for simulating light propagation in tissue.  
Based on random movement, a large number of photon packets are traced yielding an 
accurate model of photon transport.  A grid system can be used to store the absorption, 
diffuse reflectance, and transmittance quantities.  Each photon packet is launched from 
the same location with a weight of one.  Once hitting an interaction site, a fraction of the 
light is absorbed. The dropped weight is recorded and the weight is updated.  The 
remaining portion continues to propagate through scattering events determined by 
statistically sampling the probability distributions for step size and deflection angle.  If a 
packet hits a boundary, it can be internally reflected or transmitted based on probability.  
The weight of transmitted light is recorded.  If a photon packet is transmitted at the 
surface of the tissue, the weight is recorded in the diffuse reflectance grid.  When a 
photon packet exits the medium or the weight becomes too small, it is considered dead 
and a new photon packet is launched.  This is continued to obtain a realistic 
representation of light propagation. 
 
2.2 OIR History 
Oblique-incidence reflectometry (OIR) can separate absorption and scattering properties 
based on relative measurements whereas normal-incidence reflectometry requires 
absolute measurements that can be difficult to obtain.  OIR breaks the symmetry in the 
diffuse reflectance pattern resulting in a more robust clinical system.  The setup 
incorporating oblique incidence light continues to evolve.  Early research of oblique-
incidence reflectometry tested the application of diffusion theory by comparing Monte 
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Carlo simulations and experimental results from a video reflectometer2.  The next trial 
implemented a fiber optic probe3, which was soon followed by the addition of the 
spectrograph4.  Lastly, the probe was modified in size to be more appropriate for skin 
cancer, data acquisition was made to be real time, and clinical tests were performed. 
 
The Optical Imaging Lab at Texas A&M University developed the first OIR imaging 
system.  Garcia-Uribe et al.5 classified non-pigmented lesions as benign or cancerous 
with 100% accuracy and pigmented lesions as benign or dysplastic with 95% accuracy.  
These results are very encouraging in that OIR technology in the clinic could greatly 
reduce the number of unnecessary biopsies.  They were unable to include melanoma due 
to the size of the study, 102 lesions.  The proposed research will use the same 
technology and methods but will be larger to ensure that melanoma is included in the 
classification algorithm.      
 
2.3 Work by Others 
Spectroscopic methods 
Other researchers are also exploring the capabilities of spectroscopy to aid the physician 
in skin cancer detection.  Wallace et al.6,7 used multivariate discriminate analysis and 
neural networks to classify reflectance spectra of common nevi and melanoma.  They 
reported an accuracy rate of 86.7% for the neural network technique though the study 
did not include dysplastic nevi.  McIntosh et al.8 utilized near-infrared reflectance 
spectroscopy with multivariate analysis to group spectra from non-melanoma skin 
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cancers, pre-cancers, and benign lesions.  They described classification accuracies of 
72.4-97.7%,.  Tomatis et al.9 discriminated between melanoma and non-melanoma 
lesions with 85% accuracy using multispectral imaging.  Sigurdson et al.10 employed 
Raman spectroscopy and neural networks to categorize skin lesions, including melanoma 
with a classification performance of 80.5%.  Panjehpour et al.11 used fluorescence 
spectroscopy to classify non-melanoma skin cancers and reported that it only worked 
well in patients with fair skin.  The reports mentioned differentiate between the specified 
skin lesion classes, but none of them include melanoma skin cancers, non-melanoma 
skin cancers, atypical lesions, and benign lesions in one study.  In the clinic, in would be 
most useful to be able to use one imaging modality on all questionable lesions.  
 
Other methods 
Non-spectroscopic methods also have some interesting results.  Confocal scanning 
microscopy can image nuclear, cellular, and architectural detail in the epidermis and 
superficial dermis of melanocytic lesions12,13.  This is only useful for pigmented lesions 
as the melanin causes the cytoplasm to appear bright.  Analysis of cytologic structure 
makes it possible to discriminate between uniform cells of melanocytic nevi and atypical 
cells characteristic of melanoma.  Aberg et al.14 employed multi-frequency electrical 
impedance to categorize lesion types by the impedance relation between lesion and 
reference skin.  Voltage was applied thorough two outer electrodes on a handheld probe 
and sensed with a center electrode.  They were able to identify actinic keratosis and non-
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melanoma skin cancers from benign nevi with 98.3% accuracy and melanoma from 
benign nevi with 89.0% accuracy.   
 
Takahashi et al.15 applied magnetic resonance imaging (MRI) to establish that the signal 
intensity accessed by the tumor-to-fat contrast ratio on T2-weighed images clearly 
differentiated between melanoma and benign pigmented lesions.  Maurer et al.16 added 
that melanoma had a higher SNR in both unenhanced T2-weighted and contrast 
enhanced fat suppression images, as well as a higher CNR in fat suppression sequences.  
More recently, Pennasilico et al.17 utilized MRI with the contrast agent, gadopentetate 
dimeglumine, to evaluate parameters that may be used to differentiate between 
melanoma and benign lesions.  The enhancement rate in the first minute was found to be 
significantly greater for melanomas and the signal-time intensity curves for melanoma 
were different than those for benign lesions.  The mention MRI parameters provide 
limited differentiation ability at this time.   
 
As discussed previously asymmetry is a distinguishing attribute of melanoma.  Using 
symmetric distance variations and a backpropagation neural network, Ng et al.18 have 
sorted symmetrical and asymmetrical lesions with 80% accuracy.  This technique may 
prove useful though they have not yet tried to classify lesions.  Piantanelli et al.19  
studied fractal analysis of boundary irregularity to find an increasing linear regression 
from common nevi to dysplastic nevi to melanomas.  Common nevi and melanoma may 
be distinguished using this method, but there is too much overlap to separate dysplastic 
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nevi.  The fractal dimension may be valuable when used in combination with other 
diagnostic parameters.  Though research is moving forward, there is still a need for a 
device that can discriminate all types of lesions with high accuracy. 
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CHAPTER III 
EXPERIMENTAL SETUP 
 
The OIR system includes a light source, optical multiplexer, fiber optic probe, imaging 
spectrograph, charge coupled device (CCD) camera, and computer (Figure 1).  The 150 
W halogen light source (Fiberoptics Incorporated, SOL-R 150DC) provides stable white 
light output with negligible ultraviolet light.  The optical multiplexer (Ocean Optics, 
MPM-2000) illuminates five source fibers one at a time.  The aluminum probe was 
custom made by Ocean Optics consisting of five source fibers and 24 collection fibers.  
200 μm plastic-clad silica source fibers were positioned linearly as shown in Figure 2.  
When the probe is placed perpendicular to the area of interest, the center source fiber is 
normal to the surface of incidence.  The outer source fibers are situated at 45 degrees and 
CCD camera 
Imaging 
spectrograph 
Halogen 
light source 
Optical 
multiplexer 
Probe Computer 
Collection 
fibers 
Incidence 
fibers 
Figure 1. Schematic of OIR system 
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the remaining source fibers are at 25 degrees.  Once the light is delivered to the area of 
interest, it interacts with the medium and the diffuse reflectance is collected by detection 
fibers.  The custom made fiber bundle (Fiberguide Industries) consists of 100 μm silica-
silica collection fibers that form two linear arrays on the probe tip.  The fiber bundle is 
connected to the imaging spectrograph (Newport, Oriel MS 257) that disperses light into 
its component wavelengths and captures the optical spectra with a CCD camera.  The 
4.5 mm 
Collection fibers (100 μm) 
Oblique incidence  
source fiber 
1.8 mm 
1.4 mm 
2 mm 
5 mm 
2 mm 
Figure 2. Diagram of probe tip 
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CCD chip has a 512 x 512 pixel chip that measures 12.3 x 12.3 mm2.   To prevent 
overlapping, 21 fibers were fit to the CCD chip with 3.6 nm resolution.  The 
specifications of the spectrograph and CCD chip allow for a 290 nm wavelength range, 
which was selected to be 455 – 765 nm.  Light in the visible range is best for this 
application because ultraviolet light is unsafe for patients and infrared light is not as 
sensitive for this purpose.  Spatio-spectral images are automatically saved on the 
computer future data analysis.  The system is built on portable cart that can be easily 
moved from room to room (Figure 3). 
 
Figure 3. Picture of OIR system
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CHAPTER IV 
PRELIMINARY EXPERIMENT 
 
4.1 Calibration and Validation 
The system was calibrated and validated using liquid phantoms prepared with varying 
amounts of Trypan blue as the absorbers and polystyrene microspheres as the scatterers.  
A spectrophotometer used collimated transmission to measure the absorption coefficient 
for each phantom.  The reduced scattering coefficient was calculated using Mie theory20, 
which is based on known parameters of the microspheres.  Three phantoms with 
different optical properties were used to calibrate the system.  The diffuse reflectance 
was collected from each phantom by gently immersing the probe tip with the collection 
fibers normal to the surface.  Calibration factors for each fiber and phantom were 
averaged and recorded for future data collection.  In the same manner, the diffuse 
reflectance was collected from three additional phantoms to validate the system by 
extracting optical properties. Diffusion theory or scalable Monte Carlo can be used to 
calculate the absorption and scattering coefficients.  The optical properties chosen for the 
phantoms allowed the diffusion theory method.  The experimental and expected results 
are shown in Figure 4 at varying wavelengths.  The absorption and scattering properties 
have good agreement. 
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4.2 Diffusion Theory 
Diffusion theory is based on the diffusion approximation2 of the transport equation 
where the diffuse photon intensity is assumed to be uniform in all directions.  The 
Figure 4. Expected and estimated optical properties (a) Absorption 
coefficient for phantom 1, (b) scattering coefficient for phantom 1, (c) 
absorption coefficient for phantom 2, (d) scattering coefficient for
phantom 2 
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fluence rate distribution from a point source can then be solved under the same 
approximation.  Calculation of the absorption and scattering coefficients is derived from 
the modified diffusion theory-based model, though it does not accurately model “near 
diffuse reflectance”, reflectance in the range of 1 transport mean free paths (mfp’) of the 
source21.  This problem can be avoided by only using “far diffuse reflectance,” beyond 1 
mfp’ of the source.  The optical properties for the phantoms were chosen so that the mfp’ 
would be less than distance between the source and collection fibers.  For normally 
incident light, the diffuse reflectance is modeled by two isotropic point sources; one 
positive source located below the tissue surface and one negative located above the 
tissue surface.  For oblique incidence (Figure 5), the positive point source is the same 
distance from the incident light, but the tissue depth is modified by Snell’s Law.  
Light beam
ds
Δx = dssin(αt)
αi
αt
Mirror line
Figure 5. Schematic of obliquely incident light 
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According to Wang and Jacques22, the distance from the point of incidence to the 
positive point source (ds) is defined by   
 
'35.0
13
sa
s Dd μμ +==  (4.1) 
where μa is the absorption coefficient, μs’ is the reduced scattering coefficient, and D is 
the diffusion coefficient.  When using oblique incidence, there is a shift of the point 
sources in the x direction.  Using elementary geometry, the shift (Δx) is defined by 
 
'35.0
)sin(
)sin(
sa
t
tsdx μμ
αα +==Δ  (4.2) 
where αt is the angle of refraction.  Diffuse reflectance can be measured at multiple 
wavelengths.  The position of the diffuse reflectance from the incident light can be 
obtained from the reflectance profile at a particular wavelength.   Figure 6 shows the 
normalized reflectance profile at the wavelength of 576 nm for absorption and scattering 
coefficients of 0.39 cm-1 and 12.77 cm-1, respectively.  The diffuse reflectance can be 
calculated by the modified two-source diffusion theory model4, 
 
⎥⎥⎦
⎤
⎢⎢⎣
⎡ −++Δ+−+Δ−= 3
2
22
3
11 )exp()1)(2()exp()1(
4
1')1()(
1
ρ
ρμρμ
ρ
ρμρμ
π
effeffbeffeff
s
zzz
aRxR  (4.3) 
where sR  is specular reflection, 'a  is albedo, x  is the distance between the point of 
observation on the tissue surface and the point of incidence, zΔ  is the distance between 
the virtual boundary and the tissue depth, bz  is the distance between the virtual 
boundary and the tissue surface, and 1ρ  and 2ρ are the distances between the point 
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sources and the point of observation.  Applying nonlinear least squares fit to the 
reflectance expression yields the effective attenuation coefficient (μeff), defined by 
 
D
eff aμμ =  (4.4) 
The diffusion coefficient can be calculated by 
 
)sin(3 t
xD α
Δ=  (4.5) 
Using Equations 3.2-3.4, the diffuse reflectance profile, and the two-source diffusion 
theory model, the absorption and reduced scattering coefficients can be calculated by the 
following equations: 
Figure 6. Normalized reflectance profile at wavelength 576 nm used to
deduce optical properties 
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μμ Δ=  (4.6) 
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s x
μαμ 35.0)sin(' −Δ=  (4.7) 
4.3 Scalable Monte Carlo 
Scalable Monte Carlo allows for a single simulation to be used to fit data and extract 
optical properties23.  This method is especially useful for “near diffuse reflectance”, 
when the collection fibers are further than 1 mfp’ from the source fibers.  If the 
anisotropy factor and refractive index do not change, it is possible to extract the diffuse 
reflectance for one set of optical coefficients from one Monte Carlo simulation with 
another set of coefficients.  Using Beer’s Law and simulated time-resolved diffuse 
reflectance, ( , )rR tρ , for certain reference values, arμ  and srμ , the diffuse reflectance 
can be obtained for a different absorption parameter, aμ ,   
 ( )( , ) ( , ) expr a arR t R t ctρ ρ μ μ= − −⎡ ⎤⎣ ⎦  (4.8) 
where c is the speed of light.  Changing the scattering coefficient alters the photon path 
length and the time by the scaling factor s
sr
μ
μ .  This affects the diffuse reflectance by a 
power of three; two for the area and one for time. 
 
3
( , ) ,s s sr
rs rs rs
R t R tμ μ μρ ρμ μ μ
⎛ ⎞ ⎛ ⎞= ⎜ ⎟ ⎜ ⎟⎝ ⎠ ⎝ ⎠
 (4.9) 
When both the absorption and scattering coefficients are changed, Equation 4.8 and 
Equation 4.9 are both used.  Applying nonlinear regression, the measured time-resolved 
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diffuse reflectance can be used to calculate the optical properties of an unknown 
medium.  
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CHAPTER V 
CLINICAL EXPERIMENT 
 
5.1 Data Collection 
Images and histopathological diagnoses were obtained from 250 lesions at the University 
of Texas M.D. Anderson Cancer Center (Melanoma and Skin Center).  Dr. Madeleine 
Duvic and other dermatologists identified suspicious skin lesions that were going to be 
biopsied for routine care.  Patients were asked to participate in the study and sign an 
informed consent approved by the IRB under protocol DM98-275.  Because the OIR 
system was built onto a portable cart, it was easily moved to the patient exam rooms.  
The lights were turned off to remove unknown sources of light.  The oblique-incidence 
spectroscopic probe was used to collect spatio-spectral images from skin lesions and 
adjacent healthy skin.  Baby oil was dropped onto the skin to couple the light in between 
the probe and the skin.  Data was collected with the probe placed perpendicular to the 
collection site ensuring contact but not compressing the skin.  At each position five 
images are collected, one from each of the source fibers.  The probe was rotated 45 
degrees and repeated until images of four different probe positions were achieved.  A 
digital image was obtained from each lesion using a Canon camera with an attached 
Dermlite lens.  After the measurements were complete, the physicians removed the 
lesion and sent it for biopsy.  Histopathological diagnoses was performed by 
UTMDACC and reported within 3 to 4 days.   
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The lesions included in data analysis include benign common nevi (CN), mildly 
dysplastic nevi (DN1), moderately dysplastic nevi (DN2), severely dysplastic nevi 
(DN3), melanoma in situ (M1), invasive melanoma (M2), warts (W), actinic keratosis 
(AK), seborrheic keratosis (AK), basal cell carcinoma (BCC), and squamous cell 
carcinoma (SCC).  Other lesion types were excluded from data analysis at this time.  The 
categories were separated into two groups, 111 pigmented lesions and 65 non-pigmented 
lesions.  The number of lesions captured and a representative Dermlite image of each 
type are shown in Table I and Table II.  The images show the difficulty that arises when 
tying to diagnose skin lesions visually.  Image acquisition from five source fibers at four 
probe positions resulted in 20 images being collected from each lesion and 
corresponding normal tissue.  An example spatio-spectral image for normal skin is 
shown in Figure 7. 
R
elative
value
R
elative
value
Figure 7.  Spatio-spectral image of normal skin  
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Lesion Type Number of Lesions Dermlite example image
Common nevi 19
Actinic keratosis 3
Seborrheic keratosis 12
Mild dysplastic nevi 21
Moderate dysplastic nevi 41
Severe dysplastic nevi 5
Melanoma 5
Melanoma in situ 5
Total 111
Table I. Pigmented Lesions 
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Lesion Type Number of Lesions Dermlite example image
Common nevi 4
Warts 3
Actinic keratosis 11
Seborrheic keratosis 2
Basal cell carcinoma 28
Squamous cell carcinoma 14
Severe dysplastic nevi 1
Melanoma in situ 2
Total 65
Table II. Non-Pigmented Lesions 
  
25
5.2 Data Analysis 
To classify OIR data, an image processing algorithm was developed and evaluated for 
both pigmented and non-pigmented lesions.  Each lesion image was divided by the 
related healthy tissue image to normalize the data.  This is based on the assumption that 
the melanin content of healthy skin tissue will correlate with that of the imaged lesion.  
Melanoma
Melanoma in situ
Severe dysplastic nevi
Actinic keratosis
Seborrheic keratosis
Common nevi
Mild dysplastic nevi
Moderate dysplastic nevi
Common nevi
Mild dyplastic nevi
Moderate dyplastic nevi
Actinic keratosis
Seborrheic keratosis
Common nevi
Mild dysplastic nevi
Moderate dysplastic nevi
Common nevi
Actinic keratosis
Seborrheic keratosis
Mild dysplastic nevi
Moderate dysplatic nevi
Severe dyplastic nevi
Melanoma
Melanoma in situ
Figure 8. Breakdown of pigmented lesions 
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Basal cell carcinoma
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Common nevi
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Actinic keratosis
Seborrheic keratosis
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The skin is not homogeneous and will vary within the collection site.  To reduce the 
error, the collection fiber intensity found at each probe position was averaged for each 
source fiber.  For simplification, groups were separated into two classes at a time.  
Features were extracted from the pigmented lesions to break them into two groups.  This 
was repeated for the subgroups until the desired categories were achieved.  The same 
procedure was followed for the non-pigmented lesions.  Figure 8 and Figure 9 illustrate 
the classification order followed for pigmented and non-pigmented lesions, respectively.      
 
Selection of features 
The following describes the method used to establish optimal features for each of the 
five classifiers.  Features were extracted to divide each group in stages.  The continuous 
wavelet transform (CWT) was employed to extract the best five features per fiber in the 
two classes under analysis.  The CWT of ( )f t  with respect to the wavelet function Ψ is 
defined as follows24:  
 1( , ) ( ) t bWf b a f t dt
aa
∞
Ψ
−∞
−⎛ ⎞= Ψ ⎜ ⎟⎝ ⎠∫ , 0a <  (5.1) 
The Morlet analyzing wavelet was used varying a  from 1 to 16 and b along the 
wavelength range.  The one dimensional data, intensity as a function of wavelength, is 
converted into two dimensional information, wavelet transformation as a function of b 
and a.  CWT features are extracted from the two dimensional data yielding mean, 
standard deviation, skewness, and kurtosis values for varying wavelength ranges.  The 
five most effective features for each fiber were chosen using the Fisher distance (FD) as 
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a measure of separability between classes.  Redundant features were removed from the 
list and those remaining were narrowed down to the best 20 also using the Fisher 
distance.   
The Fisher distance and the receiver operating characteristic (ROC) curve can 
both be used as a measure of separability.  The results for each measure are comparable 
though there can be minor differences.  The Fisher distance is calculated by 
 22
2
121 σσμμ +−=FD  (5.2)   
where 1μ  and 2μ  denote class means and 1σ  and 2σ  denote class standard deviations.  
The ROC curve is obtained by plotting the true positive fraction versus the false positive 
fraction for different cutoff levels.  The true positive fraction is when the test is positive 
and it is correct.  The false positive fraction is when the test is positive and it is incorrect.  
When there is good separation, the area under the ROC curve will be close to 1.  This 
signifies that when the positive tests are correct, there are few incorrect and vice versa.    
The Genetic Algorithm (GA) was utilized to find the most effective combination 
of features.  It uses methods of population, crossover, and mutation to find the optimal 
selection of features25.  The first population is a random set of chromosomes that 
represent 1000 possible solutions.  According to classification ability, each chromosome 
is given a fitness value defined as follows 
 Fitness value = FD * ROCA (5.3) 
where ROCA is the area under the receiver operating characteristic curve.  A second 
population is generated according to the fitness values.  Chromosomes that divide 
classes most effectively are selected to reproduce.  The parent chromosomes crossover at 
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1, 2, or 3 randomly chosen points. The mutation operation randomly changes the 
offspring resulting from crossover to prevent solutions from falling into a local optimum.  
This process is repeated until the new population is complete.  The generations continue 
to evolve until a specified condition is satisfied.  At this point, the best solution in the 
final population is chosen as an optimal combination of features.  For this study, the 
program ended, when the fitness value ceased to improve over many generations or a 
maximum number of generations was reached.  This process was repeated several times 
and the best feature combination was selected.  The features included in the first 
classifier for pigmented lesions are shown in Table III.  The others may be found in the 
Appendix.   
Source 
Fiber #
Collection 
Fiber #
Statistic Wavelength 
Range
FD ROCA
sf3 20 mean 542-698 0.9566 0.8434
sf5 14 skewness 560-571 0.8773 0.8240
sf4 3 skewness 560-571 0.8833 0.8108
sf4 21 mean 498-563 0.8875 0.8003
sf5 14 mean 498-563 0.8847 0.7955
sf2 15 mean 563-701 0.8600 0.8090
sf4 4 skewness 542-578 0.8580 0.8073
sf2 14 kurtosis 494-687 0.8437 0.8066
sf3 19 mean 542-756 0.8360 0.8108
sf1 20 mean 542-756 0.8304 0.8059
sf5 20 mean 549-560 0.8176 0.8184
sf4 4 kurtosis 560-571 0.8228 0.7882
Table III.  Effective Image Features for First Classifier of Pigmented Lesions 
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Feature conditioning and classification 
The resulting features for each classifier were conditioned to remove correlations and 
reduce dimensionality.  Feature vectors were formed for each image based on the chosen 
effective feature combination.  Two steps were necessary to remove correlation.  First, 
the mean feature vector was subtracted.  Second, the feature vectors were multiplied by 
the matrix 
 ( )1 1 2, ,..., tnA e e e=  (5.4) 
where ( )neee ,...,, 21  are eigenvectors of the covariance matrix.  The within-class matrix 
(SB) and the between-class matrix (SW) were calculated to reduce dimensionality26.   
 ∑ ∑
= ∈
−−=
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jiji
j
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00 ))((  (5.6) 
To minimize the separability measure, J, the feature vectors were multiplied by the 
eigenvector corresponding to the zero eigenvalue of ),( 1 BW SS
− .   
 ),( 1 BW SSTraceJ
−=  (5.7) 
This reduces each feature vector to one dimension based on a new combined image 
feature (CIF) without losing any information. 
 A Bayes decision rule was used to separate each group based on the selected 
features.  Each classifier categorizes 1 lesion group into 2 subgroups, which for 
simplicity will be called class I and class II.  A lesion is considered to be of class I if 
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 Pr (class I | x) > Pr (class II | x) (5.8) 
Figure 10. Scatter plot of training data for pigmented lesions 
Figure 11. Scatter plot of testing data for pigmented lesions 
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Figure 12. Scatter plot of training data for non-pigmented lesions 
Figure 13. Scatter plot of testing data for non-pigmented lesions 
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Otherwise, it will belong to class II.  Using a one dimensional feature and assuming a 
Guassian distribution simplifies the criteria.  A lesion is considered to be of class I if 
 g (class I) > g (class II) (5.9) 
Otherwise, it will belong to class II.  The probabilities of a lesion belonging to a certain 
class for Guassian distributions can be calculated by   
 g (class I) 
1
2
1
1
)(
)ln( σ
μσ −−−= CIF  (5.10) 
 g (class II)
2
2
2
2
)(
)ln( σ
μσ −−−= CIF  (5.11) 
where 1μ  and 2μ  denote class means and 1σ  and 2σ  denote class standard deviations.  
For the training set, the classifier outcome was measured based on histopathology 
reports.   
  
5.3 Results 
Based on the classification features, spatio-spectral images were separated into different 
categories.  The algorithms were evaluated and validated with two thirds of the data as 
the training set and one third as the testing set. Confusion matrices and classification 
accuracies are shown in Tables IV-IX.  Scatter plots testing and training sets are shown 
in Figures 10-13.  For pigmented lesions, severe dysplastic nevi, melanoma, and 
melanoma in situ are classified with 100% accuracy in the testing set.  The other less 
severe lesions are classified with accuracies ranging from 84.21-86.67%.  There is an 
overall classification rate of 87.39%.  For non-pigmented lesions, basal cell carcinoma, 
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squamous cell carcinoma, severe dysplastic nevi, and melanoma in situ were classified 
with 85.71% accuracy in the testing set.  The other less severe lesion types were 
classified with accuracies ranging from 83.33-100%.  There is an overall classification 
rate of 90.77%.  Histopathology was used to organize the training set initially and again 
to measure the classifier with the testing set.   
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DN3_M1_M2 AK_SK CN DN1_DN2 Accuracy
DN3_M1_M2 12 100.00
AK_SK 8 100.00
CN 1 1 9 81.82
DN1_DN2 4 1 31 86.11
Total 89.55
Table IV. Training Confusion Matrix for Pigmented Lesions 
DN3_M1_M2 AK_SK CN DN1_DN2 Accuracy
DN3_M1_M2 3 100.00
AK_SK 5 2 100.00
CN 1 7 71.43
DN1_DN2 1 1 2 22 87.50
Total 84.62
Table V. Testing Confusion Matrix for Pigmented Lesions 
DN3_M1_M2 AK_SK CN DN1_DN2 Accuracy
DN3_M1_M2 15 100.00
AK_SK 13 2 86.67
CN 1 2 16 84.21
DN1_DN2 5 1 3 53 85.48
Total 87.39
Table VI. Overall Confusion Matrix for Pigmented Lesions 
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BCC_SCC_DN3_M2 AK_SK CN_W Accuracy
BCC_SCC_DN3_M2 12 1 1 85.71
AK_SK 1 5 83.33
CN_W 1 100.00
Total 85.71
Table VIII. Testing Confusion Matrix for Non-Pigmented Lesions 
BCC_SCC_DN3_M2 AK_SK CN_W Accuracy
BCC_SCC_DN3_M2 30 1 96.77
AK_SK 1 6 85.71
CN_W 1 5 83.33
Total 93.18
Table VII. Training Confusion Matrix for Non-Pigmented Lesions  
BCC_SCC_DN3_M2 AK_SK CN_W Accuracy
BCC_SCC_DN3_M2 42 2 1 93.33
AK_SK 2 11 84.62
CN_W 1 6 85.71
Total 90.77
Table IX. Overall Confusion Matrix for Non-Pigmented Lesions 
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CHAPTER VI 
CONCLUSION 
 
For patients with melanoma, finding the tumor early is the key to survival.  The current 
OIR system can image lesions as small as 2 mm in diameter.  It can accurately calculate 
optical properties as compared to estimated values from collimated transmission and Mie 
theory.  It also has good classification results from data collected in recent clinical 
studies.  Data analysis involved lengthy statistical procedures to extract image features.  
Overall classification accuracies ranged from 84.21-100% for pigmented lesions and 
84.62-93.33% for non-pigmented lesions.  The pigmented algorithm was able to identify 
all of the high risk lesions (DN3, M1, M2).  Six lesions were incorrectly put into this 
category, but this is preferable over the problem of classifying high risk lesions as 
benign.  The non-pigmented algorithm classified the high risk lesions (BCC, SCC, DN3, 
M2) in the testing set with over 85% accuracy.  It is likely that the rate is lower due to an 
increased number of lesions.  The next step for this technology is to establish a 
statistically significant database for different types of skin lesions as well as normal skin.  
Furthermore, physiological parameters responsible for diagnostic optical features need to 
be identified.  Though it may be some time before any technology can replace the 
biopsy, OIR could certainly aid the physician in deciding which lesions to biopsy.  This 
could reduce the number of biopsies for benign lesions, as well as help identify lesions 
that may be dangerous.  This technology may be able to bring attention to a lesion that 
would otherwise be passed up.  OIR is a strong competitor with other methods for non-
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invasive skin cancer detection.  This technology has a promising outlook for skin cancer 
diagnosis and could also be expanded to ocular, cervical, oral, and GI cancers. 
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APPENDIX 
Source Fiber 
#
Collection 
Fiber # Statistic
Wavelength 
Range FD ROCA
sf5 18 skewness 600-763 1.1417 0.8794
sf5 19 mean 592-730 1.0823 0.8704
sf3 18 kurtosis 658-687 1.0329 0.8601
sf1 15 kurtosis 654-687 1.0012 0.8593
sf5 16 kurtosis 661-687 0.9971 0.8477
sf5 14 skewness 647-658 0.9915 0.8391
sf2 19 skewness 600-690 0.9558 0.8362
sf2 21 skewness 600-719 0.9758 0.8136
sf3 21 kurtosis 679-698 0.9371 0.8465
sf3 15 kurtosis 672-763 0.9261 0.8366
sf5 14 kurtosis 658-730 0.9215 0.8379
Table X. Effective Image Features for Second Classifier of Pigmented Lesions 
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Source 
Fiber #
Collection 
Fiber #
Statistic Wavelength 
Range
FD ROCA
sf3 14 kurtosis 574-603 0.9139 0.8069
sf5 15 skewness 538-611 0.8318 0.8090
sf3 19 kurtosis 520553 0.8224 0.8077
sf5 10 kurtosis 574-603 0.8376 0.7823
sf5 17 skewness 542-571 0.8202 0.7738
sf5 2 skewness 553-563 0.8085 0.7823
sf3 13 kurtosis 542-571 0.7748 0.7937
sf5 11 kurtosis 574-600 0.7058 0.7602
sf1 14 kurtosis 574-603 0.7254 0.7390
sf4 21 kurtosis 600-603 0.7145 0.7453
sf4 18 kurtosis 520-553 0.6934 0.7606
Table XI. Effective Image Features for Third Classifier of Pigmented Lesions 
Source 
Fiber #
Collection 
Fiber #
Statistic Wavelength 
Range
FD ROCA
sf3 21 kurtosis 629-669 0.8253 0.8006
sf5 16 mean 560-752 0.8379 0.8189
sf1 21 skewness 618-672 0.8417 0.8156
sf3 14 skewness 618-676 0.8447 0.8350
sf5 1 mean 538-723 0.8463 0.8100
sf5 17 mean 607-737 0.8474 0.8194
sf3 17 skewness 618-676 0.8508 0.8028
sf3 11 kurtosis 636-665 0.8652 0.8006
sf3 11 skewness 618-672 0.8734 0.8233
sf3 1 mean 538-723 0.8787 0.8067
sf5 5 kurtosis 647-665 0.8924 0.8389
sf3 16 skewness 618-683 0.9004 0.8228
Table XII. Effective Image Features for First Classifier of Non-Pigmented Lesions 
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Source 
Fiber #
Collection 
Fiber #
Statistic Wavelength 
Range
Final 
Wavelength
FD ROCA
sf5 18 skewness 578 607 1.9106 0.9725
sf1 20 skewness 611 621 1.7598 0.956
sf2 20 mean 560 730 1.6391 0.989
sf3 16 mean 527 567 1.6946 0.956
sf2 1 kurtosis 687 708 1.5901 0.9725
sf2 12 skewness 625 661 1.5619 0.9615
sf3 15 mean 560 730 1.4996 0.967
sf2 19 mean 556 589 1.4964 0.9505
sf1 1 skewness 665 748 1.4505 0.9286
Table XIII. Effective Image Features for Second Classifier of Non-Pigmented Lesions 
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